1. LePrevost C., Levy-Leblond E., Virelizier J.L., Dupuy J.M., Immunopathology of mouse hepatitis virus type 3 infection: I. Role of humoral and cell-mediated immunity in resistance mechanisms. J Immunol 1975;114:221–225.
2. Levy G.A., Leibowitz J.L., Edgington T.S. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med 1981;154:1150–1163.
3. Dindzans V.J., Skamene E., Levy G.A. Susceptibility/ resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H-2-linked genes. J Immunol 1986;137:2355–2360.
4. Parr R., Fung L.S., Reneker J., Myers-Mason N., Leibowitz J., Levy G. Association of mouse fibrinogen like protein (musfiblp) with murine hepatitis virus induced prothrombinase activity. 1994 (submitted).
5. Gallily R., Warwick A., Bang F.B. Effect of cortisone on genetic resistance to mouse hepatitis virus in vivo and in vitro. Proc Natl Acad Sci USA 1964;51:1158–1164.